Literature DB >> 16740140

Polymorphisms in innate immunity genes and risk of non-Hodgkin lymphoma.

Matthew S Forrest1, Christine F Skibola, Tracy J Lightfoot, Paige M Bracci, Eleanor V Willett, Martyn T Smith, Elizabeth A Holly, Eve Roman.   

Abstract

Genetic variation in innate immunity may alter host-pathogen defence mechanisms and promote aberrant immune responses and non-Hodgkin lymphoma (NHL). To test this hypothesis, we investigated polymorphisms in innate immune genes in a pooled analysis of two population-based case-control studies of NHL from the San Francisco Bay Area (308 cases, 684 controls) and UK (596 cases, 758 controls). The caspase recruitment domain-containing protein 1007fs homozygote variant was positively associated with NHL risk (odds ratios (OR) = 3.1, 95% confidence intervals (CI) 1.1-8.8), whereas the toll-like receptor 4 1063A>G variant allele was inversely associated with diffuse large cell lymphoma (OR = 0.67, 95% CI 0.45-0.99). These results suggest that variation in innate immune genes may alter NHL susceptibility.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16740140     DOI: 10.1111/j.1365-2141.2006.06141.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  29 in total

Review 1.  Inhibition of pattern recognition receptor-mediated inflammation by bioactive phytochemicals.

Authors:  Ling Zhao; Joo Y Lee; Daniel H Hwang
Journal:  Nutr Rev       Date:  2011-06       Impact factor: 7.110

2.  Prognostic significance of host immune gene polymorphisms in follicular lymphoma survival.

Authors:  James R Cerhan; Sophia Wang; Matthew J Maurer; Stephen M Ansell; Susan M Geyer; Wendy Cozen; Lindsay M Morton; Scott Davis; Richard K Severson; Nathaniel Rothman; Charles F Lynch; Sholom Wacholder; Stephen J Chanock; Thomas M Habermann; Patricia Hartge
Journal:  Blood       Date:  2007-02-27       Impact factor: 22.113

3.  Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma.

Authors:  James R Cerhan; Stephen M Ansell; Zachary S Fredericksen; Neil E Kay; Mark Liebow; Timothy G Call; Ahmet Dogan; Julie M Cunningham; Alice H Wang; Wen Liu-Mares; William R Macon; Diane Jelinek; Thomas E Witzig; Thomas M Habermann; Susan L Slager
Journal:  Blood       Date:  2007-09-07       Impact factor: 22.113

Review 4.  Unleashing the therapeutic potential of NOD-like receptors.

Authors:  Kaoru Geddes; João G Magalhães; Stephen E Girardin
Journal:  Nat Rev Drug Discov       Date:  2009-06       Impact factor: 84.694

Review 5.  Toll-like receptors and cancer.

Authors:  Seth Rakoff-Nahoum; Ruslan Medzhitov
Journal:  Nat Rev Cancer       Date:  2008-12-04       Impact factor: 60.716

6.  A pooled investigation of Toll-like receptor gene variants and risk of non-Hodgkin lymphoma.

Authors:  Mark P Purdue; Qing Lan; Sophia S Wang; Anne Kricker; Idan Menashe; Tong-Zhang Zheng; Patricia Hartge; Andrew E Grulich; Yawei Zhang; Lindsay M Morton; Claire M Vajdic; Theodore R Holford; Richard K Severson; Brian P Leaderer; James R Cerhan; Meredith Yeager; Wendy Cozen; Kevin Jacobs; Scott Davis; Nathaniel Rothman; Stephen J Chanock; Nilanjan Chatterjee; Bruce K Armstrong
Journal:  Carcinogenesis       Date:  2008-11-24       Impact factor: 4.944

Review 7.  Host genetics in follicular lymphoma.

Authors:  James R Cerhan
Journal:  Best Pract Res Clin Haematol       Date:  2011-05-05       Impact factor: 3.020

8.  Polymorphisms in pattern-recognition genes in the innate immunity system and risk of non-Hodgkin lymphoma.

Authors:  Wei Hu; Bryan A Bassig; Jun Xu; Tongzhang Zheng; Yawei Zhang; Sonja I Berndt; Theodore R Holford; H Dean Hosgood; Brian Leaderer; Meredith Yeager; Idan Menashe; Peter Boyle; Kaiyong Zou; Yong Zhu; Stephen Chanock; Qing Lan; Nathaniel Rothman
Journal:  Environ Mol Mutagen       Date:  2012-10-11       Impact factor: 3.216

9.  Variation in innate immunity genes and risk of multiple myeloma.

Authors:  Mark P Purdue; Qing Lan; Idan Menashe; Tongzhang Zheng; Yawei Zhang; Meredith Yeager; H Dean Hosgood; Shelia H Zahm; Stephen J Chanock; Nathaniel Rothman; Dalsu Baris
Journal:  Hematol Oncol       Date:  2011-03       Impact factor: 5.271

10.  A two-stage evaluation of genetic variation in immune and inflammation genes with risk of non-Hodgkin lymphoma identifies new susceptibility locus in 6p21.3 region.

Authors:  James R Cerhan; Zachary S Fredericksen; Anne J Novak; Stephen M Ansell; Neil E Kay; Mark Liebow; Ahmet Dogan; Julie M Cunningham; Alice H Wang; Thomas E Witzig; Thomas M Habermann; Yan W Asmann; Susan L Slager
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-08-21       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.